Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC receives funding to advance cattle vaccines
The funding will support studies into bovine babesiosis and bovine tuberculosis vaccines to enhance cattle welfare.

The grants will support research into bovine babesiosis and bovine tuberculosis vaccines. 

Two international 'pump-prime' grants amounting to almost £168,000 have been awarded to the Royal Veterinary College (RVC) to advance research into cattle vaccines.

The funding from the International Veterinary Vaccinology Network (IVVN) will support studies into bovine babesiosis and bovine tuberculosis vaccines to enhance cattle welfare.

The first grant, amounting to £89,000, will support the investigation of the genetic diversity and vaccine potential of thrombospondin-repeat domain (TSR) proteins against bovine babesiosis.

The second grant, totalling nearly £79k, will use Nanopore DNA sequencing to improve understanding of genetic diversity in bovine tuberculosis (bTB) strains circulating in Algeria.

Vaccinology lecturer Dr Ellen Knuepfer will lead the research into TSR alongside Dr Silvina Wilkowsky, an independent researcher based at the Institute of Agricultural Biotechnology and Molecular Biology, Argentina.

She said: “This funding will allow us to test a group of proteins called TSR proteins not only on a genetic level, but also explore their function, and application as vaccine antigen to protect cattle from this often fatal disease.”

Dr Sharon Kendall, associate professor in molecular bacteriology and Dr Dong Xia, senior lecturer in bioinformatics at the RVC will be leading the research into bovine tuberculosis.

They will work alongside Dr Rachel Tanner, associate professor of One Health at the University of Oxford and Dr Mammar Khames, researcher and lecturer at the University of Medea, Algeria. 

Dr Tanner said: “This is an excellent opportunity to further strengthen links between Oxford and RVC, as well as form a new partnership with researchers at Medea University. The project brings together a broad range of expertise to create a team that is greater than the sum of its parts, tackling the important global One Health issue of bovine TB.”

Dr Khames added: “As a veterinarian and zoonotic disease researcher in Medea University, Algeria, I'm delighted to be working with collaborators from the RVC and Oxford University on this project, which will enable me to acquire skills in the field of bovine tuberculosis research. Let's hope this will lead to promising results and a wider project in the future.”

Image (C) RVC.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.